These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38695555)
1. Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications. Dai J; Jia J; Zhang F; Liu K; Xi Y; Yuan P; Mao L; Bai X; Wei X; Wang B; Li J; Xu Y; Liu T; Chang S; Shao Y; Guo J; Ying J; Si L Cancer Res Commun; 2024 May; 4(5):1351-1362. PubMed ID: 38695555 [TBL] [Abstract][Full Text] [Related]
2. Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy. Dai J; Bai X; Gao X; Tang L; Chen Y; Sun L; Wei X; Li C; Qi Z; Kong Y; Cui C; Chi Z; Sheng X; Xu Z; Lian B; Li S; Yan X; Tang B; Zhou L; Wang X; Xia X; Guo J; Mao L; Si L J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36593066 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas. Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970 [TBL] [Abstract][Full Text] [Related]
4. Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations. Jurmeister P; Wrede N; Hoffmann I; Vollbrecht C; Heim D; Hummel M; Wolkenstein P; Koch I; Heynol V; Schmitt WD; Thieme A; Teichmann D; Sers C; von Deimling A; Thierauf JC; von Laffert M; Klauschen F; Capper D J Pathol; 2022 Jan; 256(1):61-70. PubMed ID: 34564861 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma. Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068 [TBL] [Abstract][Full Text] [Related]
6. Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma. Fröhlich A; Sirokay J; Fietz S; Vogt TJ; Dietrich J; Zarbl R; Florin M; Kuster P; Saavedra G; Valladolid SR; Hoffmann F; Flatz L; Ring SS; Golletz C; Pietsch T; Strieth S; Brossart P; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D EBioMedicine; 2020 Sep; 59():102962. PubMed ID: 32861198 [TBL] [Abstract][Full Text] [Related]
7. Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis. Wrede N; Hoffmann I; Vollbrecht C; Koch I; Wolkenstein P; Klauschen F; Capper D; von Laffert M; Jurmeister P Pathol Res Pract; 2022 Jan; 229():153689. PubMed ID: 34844086 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive clinicopathological and molecular analysis of primary malignant melanoma of the oesophagus. Tsuyama S; Kohsaka S; Hayashi T; Suehara Y; Hashimoto T; Kajiyama Y; Tsurumaru M; Ueno T; Mano H; Yao T; Saito T Histopathology; 2021 Jan; 78(2):240-251. PubMed ID: 32654197 [TBL] [Abstract][Full Text] [Related]
9. Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review. Sanlorenzo M; Ribero S; Osella Abate S; Mariani S; Strignano P; Salizzoni M; Savoia P; Fierro MT; Quaglino P G Ital Dermatol Venereol; 2020 Oct; 155(5):680-682. PubMed ID: 33295742 [TBL] [Abstract][Full Text] [Related]
10. Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients. Seremet T; Koch A; Jansen Y; Schreuer M; Wilgenhof S; Del Marmol V; Liènard D; Thielemans K; Schats K; Kockx M; Van Criekinge W; Coulie PG; De Meyer T; van Baren N; Neyns B J Transl Med; 2016 Aug; 14(1):232. PubMed ID: 27484791 [TBL] [Abstract][Full Text] [Related]
11. Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data. Jammula S; Katz-Summercorn AC; Li X; Linossi C; Smyth E; Killcoyne S; Biasci D; Subash VV; Abbas S; Blasko A; Devonshire G; Grantham A; Wronowski F; O'Donovan M; Grehan N; Eldridge MD; Tavaré S; ; Fitzgerald RC Gastroenterology; 2020 May; 158(6):1682-1697.e1. PubMed ID: 32032585 [TBL] [Abstract][Full Text] [Related]
12. Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma. Liu D; Yang X; Wu X Front Immunol; 2021; 12():663495. PubMed ID: 34025664 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
14. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma. Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578 [TBL] [Abstract][Full Text] [Related]
15. DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy. Niebel D; Fröhlich A; Zarbl R; Fietz S; de Vos L; Vogt TJ; Dietrich J; Sirokay J; Kuster P; Saavedra G; Ramírez Valladolid S; Hoffmann F; Strieth S; Landsberg J; Dietrich D Clin Epigenetics; 2022 Apr; 14(1):50. PubMed ID: 35410311 [TBL] [Abstract][Full Text] [Related]
16. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma. Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095 [TBL] [Abstract][Full Text] [Related]
17. Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade. Taube JM; Young GD; McMiller TL; Chen S; Salas JT; Pritchard TS; Xu H; Meeker AK; Fan J; Cheadle C; Berger AE; Pardoll DM; Topalian SL Clin Cancer Res; 2015 Sep; 21(17):3969-76. PubMed ID: 25944800 [TBL] [Abstract][Full Text] [Related]
18. Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma. Mitra S; Lauss M; Cabrita R; Choi J; Zhang T; Isaksson K; Olsson H; Ingvar C; Carneiro A; Staaf J; Ringnér M; Nielsen K; Brown KM; Jönsson G Mol Oncol; 2020 May; 14(5):933-950. PubMed ID: 32147909 [TBL] [Abstract][Full Text] [Related]
19. Characteristics and prognosis of primary malignant melanoma of the esophagus. Chen H; Fu Q; Sun K Medicine (Baltimore); 2020 Jul; 99(28):e20957. PubMed ID: 32664098 [TBL] [Abstract][Full Text] [Related]
20. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma. Kim SW; Kim YI; Mustafa B; Kim MJ; Jeong G; Ahn SM; Lim SB; Yu CS; Kim JC; Hong SM; Park IJ Mod Pathol; 2021 Jan; 34(1):141-160. PubMed ID: 32709987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]